These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Interleukin-6 deletion stimulates revascularization and new bone formation following ischemic osteonecrosis in a murine model. Kuroyanagi G; Adapala NS; Yamaguchi R; Kamiya N; Deng Z; Aruwajoye O; Kutschke M; Chen E; Jo C; Ren Y; Kim HKW Bone; 2018 Nov; 116():221-231. PubMed ID: 30125727 [TBL] [Abstract][Full Text] [Related]
23. Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate. Dela Cruz A; Grynpas MD; Mitchell J Am J Physiol Endocrinol Metab; 2016 May; 310(10):E811-20. PubMed ID: 27006198 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of neuronal migration by JONES antibody is independent of 9-O-acetyl GD3 in GD3-synthase knockout mice. Yang CR; Liour SS; Dasgupta S; Yu RK J Neurosci Res; 2007 May; 85(7):1381-90. PubMed ID: 17385751 [TBL] [Abstract][Full Text] [Related]
25. The ceramide moiety of disialoganglioside (GD3) is essential for GD3 recognition by the sialic acid-binding lectin SIGLEC7 on the cell surface. Hashimoto N; Ito S; Tsuchida A; Bhuiyan RH; Okajima T; Yamamoto A; Furukawa K; Ohmi Y; Furukawa K J Biol Chem; 2019 Jul; 294(28):10833-10845. PubMed ID: 31138648 [TBL] [Abstract][Full Text] [Related]
26. RANK-Independent Osteoclast Formation and Bone Erosion in Inflammatory Arthritis. O'Brien W; Fissel BM; Maeda Y; Yan J; Ge X; Gravallese EM; Aliprantis AO; Charles JF Arthritis Rheumatol; 2016 Dec; 68(12):2889-2900. PubMed ID: 27563728 [TBL] [Abstract][Full Text] [Related]
27. Bone marrow monocyte PECAM-1 deficiency elicits increased osteoclastogenesis resulting in trabecular bone loss. Wu Y; Tworkoski K; Michaud M; Madri JA J Immunol; 2009 Mar; 182(5):2672-9. PubMed ID: 19234161 [TBL] [Abstract][Full Text] [Related]
28. St8sia1-deficiency in mice alters tumor environments of gliomas, leading to reduced disease severity. Zhang P; Ohkawa Y; Yamamoto S; Momota H; Kato A; Kaneko K; Natsume A; Farhana Y; Ohmi Y; Okajima T; Bhuiyan RH; Wakabayashi T; Furukawa K; Furukawa K Nagoya J Med Sci; 2021 Aug; 83(3):535-549. PubMed ID: 34552288 [TBL] [Abstract][Full Text] [Related]
29. Gangliosides are essential in the protection of inflammation and neurodegeneration via maintenance of lipid rafts: elucidation by a series of ganglioside-deficient mutant mice. Ohmi Y; Tajima O; Ohkawa Y; Yamauchi Y; Sugiura Y; Furukawa K; Furukawa K J Neurochem; 2011 Mar; 116(5):926-35. PubMed ID: 21214571 [TBL] [Abstract][Full Text] [Related]
30. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio. Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014 [TBL] [Abstract][Full Text] [Related]
31. Ovariectomy-induced bone loss in Zhu S; He H; Gao C; Luo G; Xie Y; Wang H; Tian L; Chen X; Yu X; He C J Mol Endocrinol; 2018 Apr; 60(3):185-198. PubMed ID: 29339399 [TBL] [Abstract][Full Text] [Related]
32. Elimination of GD3 synthase improves memory and reduces amyloid-beta plaque load in transgenic mice. Bernardo A; Harrison FE; McCord M; Zhao J; Bruchey A; Davies SS; Jackson Roberts L; Mathews PM; Matsuoka Y; Ariga T; Yu RK; Thompson R; McDonald MP Neurobiol Aging; 2009 Nov; 30(11):1777-91. PubMed ID: 18258340 [TBL] [Abstract][Full Text] [Related]
33. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin. Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296 [TBL] [Abstract][Full Text] [Related]
34. miR-145-5p Increases Osteoclast Numbers In Vitro and Aggravates Bone Erosion in Collagen-Induced Arthritis by Targeting Osteoprotegerin. Chen Y; Wang X; Yang M; Ruan W; Wei W; Gu D; Wang J; Guo X; Guo L; Yuan Y Med Sci Monit; 2018 Jul; 24():5292-5300. PubMed ID: 30059491 [TBL] [Abstract][Full Text] [Related]
35. Herbacetin inhibits RANKL-mediated osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo. Li L; Sapkota M; Kim SW; Soh Y Eur J Pharmacol; 2016 Apr; 777():17-25. PubMed ID: 26923730 [TBL] [Abstract][Full Text] [Related]
37. Accumulation of unusual gangliosides G(Q3) and G(P3) in breast cancer cells expressing the G(D3) synthase. Steenackers A; Vanbeselaere J; Cazet A; Bobowski M; Rombouts Y; Colomb F; Le Bourhis X; Guérardel Y; Delannoy P Molecules; 2012 Aug; 17(8):9559-72. PubMed ID: 22885356 [TBL] [Abstract][Full Text] [Related]
38. RARγ is a negative regulator of osteoclastogenesis. Green AC; Poulton IJ; Vrahnas C; Häusler KD; Walkley CR; Wu JY; Martin TJ; Gillespie MT; Chandraratna RA; Quinn JM; Sims NA; Purton LE J Steroid Biochem Mol Biol; 2015 Jun; 150():46-53. PubMed ID: 25800721 [TBL] [Abstract][Full Text] [Related]
39. LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption. Luo J; Yang Z; Ma Y; Yue Z; Lin H; Qu G; Huang J; Dai W; Li C; Zheng C; Xu L; Chen H; Wang J; Li D; Siwko S; Penninger JM; Ning G; Xiao J; Liu M Nat Med; 2016 May; 22(5):539-46. PubMed ID: 27064449 [TBL] [Abstract][Full Text] [Related]
40. Ganglioside deficiency causes inflammation and neurodegeneration via the activation of complement system in the spinal cord. Ohmi Y; Ohkawa Y; Tajima O; Sugiura Y; Furukawa K; Furukawa K J Neuroinflammation; 2014 Mar; 11():61. PubMed ID: 24673754 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]